New Developments in Cancer Treatment Offer Hope

Cancer is responsible for nearly ten million deaths annually, making it a leading cause of death worldwide according to the World Health Organization. Breast, lung, and colorectal cancers are among the most common types. However, there’s good news as advancements in medical technology and science pave the way for better oncological outcomes, reduced patient burden, and ultimately longer life expectancy with improved quality of life. Two decades ago, almost all cancer patients received only cytostatic chemotherapy based solely on tumor origin, facing severe side effects and uncertain results. In recent years, significant progress has been made in cancer research with two new treatments—immunotherapy and targeted therapy—complementing or even replacing traditional chemotherapy. Today, over 50% of patients are treated using immune biomarkers and molecular characteristics of tumors regardless of their origin, yielding excellent results. Immunotherapy leverages the patient’s immune system to fight cancer either by enhancing natural defenses or creating substances that mimic immune components. Targeted therapy uses drugs designed to attack cancer cells without harming healthy ones, focusing on specific molecules necessary for cancer survival and proliferation. These advances prioritize patient care through accurate diagnosis programs, upgraded day-care units, independent clinics, cutting-edge radiologic techniques, active participation in clinical trials, and interdisciplinary approaches via Oncology Councils.